M 25, 3.5 months apart images, fin works,
    Progress Pictures 6/19/2025

    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💧 Minoxidil (topical) 5% 1x daily 2.5 years
    💊 Finasteride (oral) 1 mg 3x weekly 3 months
    Microneedling (derma pen) 1.5 mm 1x weekly 1 month
    💊 Multivitamins (oral) every other day 8 months
    the tone is 😀 positive with hair regrowth results.

    Other terms

    A 25-year-old male experienced hair regrowth after switching from topical minoxidil to a combination of topical minoxidil and oral finasteride, along with microneedling and multivitamins. He reported no significant side effects from finasteride, except mild discomfort, and emphasized the effectiveness of oral finasteride over topical solutions.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
      Clinical Trials and Hair Loss

      research Clinical Trials and Hair Loss

      1 citations , July 2018 in “Elsevier eBooks”
      This review explores the current treatments for different types of alopecia, emphasizing the need for well-designed clinical trials and highlighting that most therapies are used off-label, as only androgenetic alopecia has FDA-approved drugs.
      Hair Loss in Men and Women: Medical and Surgical Treatments for Androgenic Alopecia

      research Hair Loss in Men and Women

      April 2019 in “Advances in Cosmetic Surgery”
      The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.
      Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments

      research Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments

      March 2026 in “Preprints.org”
      This study reviewed evidence for six minimally invasive treatments for androgenetic alopecia, finding consistent support for platelet-rich plasma and topical finasteride, while other options like microneedling and intradermal dutasteride showed promise but need further and standardized research.

      research Male androgenetic alopecia

      January 2025 in “Anais Brasileiros de Dermatologia”
      This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.